![2-(4-Methylphenyl)-5,6,7,8-tetrahydroimidazo[2,1-b][1,3]benzothiazole hydrobromide](https://static.cymitquimica.com/products/3D/img/FM43025.png "Zum Vergrößern klicken")
2-(4-Methylphenyl)-5,6,7,8-tetrahydroimidazo[2,1-b][1,3]benzothiazole hydrobromide
CAS: 511296-88-1
Ref. 3D-FM43025
| 1g | Ausgelaufen | ||
| 2g | Ausgelaufen | ||
| 5g | Ausgelaufen | ||
| 10g | Ausgelaufen | ||
| 500mg | Ausgelaufen |
Produktinformation
Name:
2-(4-Methylphenyl)-5,6,7,8-tetrahydroimidazo[2,1-b][1,3]benzothiazole hydrobromide
Beschreibung:
2-(4-Methylphenyl)-5,6,7,8-tetrahydroimidazo[2,1-b][1,3]benzothiazole hydrobromide is a novel agent that has been shown to be effective in the treatment of non-small cell lung cancer. The mechanism of action involves inhibition of sirtuin (SIRT) enzymes and consequent induction of apoptosis in cancer cells. The drug also inhibits the production of mononucleotides that are essential for DNA synthesis and RNA transcription. 2-(4-Methylphenyl)-5,6,7,8-tetrahydroimidazo[2,1-b][1,3]benzothiazole hydrobromide has been tested in clinical trials for the treatment of depression. This drug has also been shown to have muscle strengthening effects by increasing levels of creatine kinase and insulin like growth factor 1 (IGF-
Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Biosynth
Langzeitlagerung:
Hinweise:
Chemische Eigenschaften
Molekulargewicht:
349.29 g/mol
Formel:
C16H17BrN2S
Reinheit:
Min. 95%
MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code:
